Rheumatology & Arthritis Learning Network

Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis by Rheumatology & Arthritis Learning Network

Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout by Rheumatology & Arthritis Learning Network

Risk Factors for COVID-19 Reinfection Among Patients With Rheumatic Diseases by Rheumatology & Arthritis Learning Network

Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.

Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.

Dr Myasoedova, from Mayo Clinic in Rochester, Minnesota, reviews recent research showing that extra-articular manifestations of rheumatoid arthritis are on the decline.

Dr Fleischmann reviews a post hoc analysis of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.

Dr Baker discusses research indicating that patients with asthma or atopic dermatitis have a significantly higher risk of developing osteoarthritis over 10 years of follow-up.

Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination.

Patricia Katz, PhD, is a professor of medicine and health policy at the University of California San Francisco.

The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—either by needing an aortic valve intervention or aortic stenosis-related death.